食品藥物管理署於106-107年度受理食品摻加西藥檢驗案件共計715件檢體,其中412件檢出西藥或非標示成分,檢出率為57.6%。依受理案件類別統計,屬縣市政府衛生局轉送消費者申請案件及司法檢警調海關等機關送驗之服務案件有554件,檢出340件(61.4%);屬衛生行政機關送驗之抽查案件有161件,檢出72件(44.7%)。依檢體標示或送驗單位指定之檢驗類別進行統計,檢出件數最多者為減肥類(218件),其次為補腎滋養類(壯陽類)(182件)。依檢出成分頻率排序,前3名依序為sibutramine、sildenafil及phenolphthalein。檢出成分除了一般西藥成分外,106-107年度亦檢出壯陽西藥成分sildenafil及tadalafil類緣物共16種,相關檢驗結果及趨勢分析將提供行政管理單位制定政策之參考。
In this study, 715 samples of commercial dietary supplements were analyzed for the presence of pharmaceutical adulterants from the year 2017 to 2018. The results showed that 57.6% (412/715) of the samples were adulterated. Among them, 554 samples from consumer service centers of the local health authorities and other governmental institutions were found 61.4% (340/554) adulterated. The 161 inspection samples from local health authorities were found 44.7% (72/161) adulterated. The most adulterated supplements, were used for weight loss (218 samples) and erectile dysfunction treatment (182 samples). The top three adulterants were sibutramine, sildenafil and phenolphthalein. In addition to pharmaceutical chemicals, sixteen analogues of sildenafil and tadalafil were found. This report will be provided to the administrative authorities as reference in policy making.